Filter

Refine by collections

Refine by date

—

Refine by access

  • Print
  • Save

Search Results

You are looking at 1 - 10 of 2,107 items for :

  • Refine by access: All content x
Clear All
Alfred King-yin Lam Cancer Molecular Pathology, School of Medicine and Menzies Health Institute Queensland, Griffith University, Gold Coast, Australia

Search for other papers by Alfred King-yin Lam in
Google Scholar
PubMed Close
and
Nassim Saremi Cancer Molecular Pathology, School of Medicine and Menzies Health Institute Queensland, Griffith University, Gold Coast, Australia

Search for other papers by Nassim Saremi in
Google Scholar
PubMed Close

thyroid cancer ( Hizawa et al . 1996 ). No detail of the cytological feature was given in the report. In 2010, Koo and coworkers from South Korea described the cytological features of five CMV-PTCs as well as reviewing 10 cases from the previous studies

Article Type:
Review Article
DOI:
https://doi.org/10.1530/ERC-17-0014
Volume/Issue:
Volume 24: Issue 4
Free access
Alfred King-yin Lam School of Medicine, Griffith University, Gold Coast, Australia

Search for other papers by Alfred King-yin Lam in
Google Scholar
PubMed Close

squamous cell carcinoma of thyroid. This review aims to address this gap of knowledge by analysing the features of squamous cell carcinoma of thyroid and their relationships with other tumours of the thyroid gland. Method Primary squamous cell

Article Type:
Review Article
DOI:
https://doi.org/10.1530/ERC-20-0045
Volume/Issue:
Volume 27: Issue 6
Free access
Tiago Bordeira Gaspar i3S – Instituto de Investigação e Inovação em Saúde, Porto, Portugal
Ipatimup – Instituto de Patologia e Imunologia Molecular da Universidade do Porto, Porto, Portugal
ICBAS – Instituto de Ciências Biomédicas Abel Salazar da Universidade do Porto, Porto, Portugal
FMUP – Faculdade de Medicina da Universidade do Porto, Porto, Portugal

Search for other papers by Tiago Bordeira Gaspar in
Google Scholar
PubMed Close
,
José Manuel Lopes i3S – Instituto de Investigação e Inovação em Saúde, Porto, Portugal
Ipatimup – Instituto de Patologia e Imunologia Molecular da Universidade do Porto, Porto, Portugal
FMUP – Faculdade de Medicina da Universidade do Porto, Porto, Portugal
Department of Pathology, Centro Hospitalar e Universitário de São João, Porto, Portugal

Search for other papers by José Manuel Lopes in
Google Scholar
PubMed Close
,
Paula Soares i3S – Instituto de Investigação e Inovação em Saúde, Porto, Portugal
Ipatimup – Instituto de Patologia e Imunologia Molecular da Universidade do Porto, Porto, Portugal
FMUP – Faculdade de Medicina da Universidade do Porto, Porto, Portugal

Search for other papers by Paula Soares in
Google Scholar
PubMed Close
, and
João Vinagre i3S – Instituto de Investigação e Inovação em Saúde, Porto, Portugal
Ipatimup – Instituto de Patologia e Imunologia Molecular da Universidade do Porto, Porto, Portugal
FMUP – Faculdade de Medicina da Universidade do Porto, Porto, Portugal

Search for other papers by João Vinagre in
Google Scholar
PubMed Close

animal models, and this review will only focus on them. In PanNENs, the most validated mouse models have been genetically programmed: (1) to conditionally activate oncogenes under relevant promoters (e.g. insulin and preproglucagon) or (2) to mimic PanNET

Article Type:
Review Article
DOI:
https://doi.org/10.1530/ERC-22-0166
Volume/Issue:
Volume 29: Issue 12
Free access
Frederic Castinetti Department of Endocrinology, Aix Marseille University, CNRS UM 7286, Assistance Publique Hopitaux de Marseille, Marseille, France

Search for other papers by Frederic Castinetti in
Google Scholar
PubMed Close
,
Jeffrey Moley Department of Surgery, Washington University School of Medicine, St Louis, Missouri, USA

Search for other papers by Jeffrey Moley in
Google Scholar
PubMed Close
,
Lois Mulligan Division of Cancer Biology and Genetics, Cancer Research Institute, Queen’s University, Kingston, Ontario, Canada

Search for other papers by Lois Mulligan in
Google Scholar
PubMed Close
, and
Steven G Waguespack Department of Endocrine Neoplasia and Hormonal Disorders, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA

Search for other papers by Steven G Waguespack in
Google Scholar
PubMed Close

review is to give detailed insights on the genetics, natural history and management of MEN2B, in addition to specific points that should be detailed in future large-scale studies. Genetics of MEN2B MEN2B, similar to MEN2A, is due to autosomal

Article Type:
Review Article
DOI:
https://doi.org/10.1530/ERC-17-0209
Volume/Issue:
Volume 25: Issue 2
Free access
Pierpaolo Trimboli Department of Nuclear Medicine and Thyroid Centre, Section of Endocrinology and Diabetology, Nuclear Medicine, Endocrine Unit, Oncology Institute of Southern Switzerland, Bellinzona, 6500, Switzerland
Department of Nuclear Medicine and Thyroid Centre, Section of Endocrinology and Diabetology, Nuclear Medicine, Endocrine Unit, Oncology Institute of Southern Switzerland, Bellinzona, 6500, Switzerland

Search for other papers by Pierpaolo Trimboli in
Google Scholar
PubMed Close
,
Ettore Seregni Department of Nuclear Medicine and Thyroid Centre, Section of Endocrinology and Diabetology, Nuclear Medicine, Endocrine Unit, Oncology Institute of Southern Switzerland, Bellinzona, 6500, Switzerland

Search for other papers by Ettore Seregni in
Google Scholar
PubMed Close
,
Giorgio Treglia Department of Nuclear Medicine and Thyroid Centre, Section of Endocrinology and Diabetology, Nuclear Medicine, Endocrine Unit, Oncology Institute of Southern Switzerland, Bellinzona, 6500, Switzerland

Search for other papers by Giorgio Treglia in
Google Scholar
PubMed Close
,
Maria Alevizaki Department of Nuclear Medicine and Thyroid Centre, Section of Endocrinology and Diabetology, Nuclear Medicine, Endocrine Unit, Oncology Institute of Southern Switzerland, Bellinzona, 6500, Switzerland

Search for other papers by Maria Alevizaki in
Google Scholar
PubMed Close
, and
Luca Giovanella Department of Nuclear Medicine and Thyroid Centre, Section of Endocrinology and Diabetology, Nuclear Medicine, Endocrine Unit, Oncology Institute of Southern Switzerland, Bellinzona, 6500, Switzerland

Search for other papers by Luca Giovanella in
Google Scholar
PubMed Close

entire process chain and are easier to manage in clinical practice. These characteristics give ProCT great potential to replace CT as a marker for detecting and managing MTC patients. To date, no review on this topic has, to our knowledge, been published

Article Type:
Review Article
DOI:
https://doi.org/10.1530/ERC-15-0156
Volume/Issue:
Volume 22: Issue 3
Free access
Mirela Diana Ilie Inserm U1052, CNRS UMR5286, Claude Bernard Lyon 1 University, Cancer Research Center of Lyon, Lyon, France
Endocrinology Department, ‘C.I. Parhon’ National Institute of Endocrinology, Bucharest, Romania

Search for other papers by Mirela Diana Ilie in
Google Scholar
PubMed Close
,
Alexandre Vasiljevic Inserm U1052, CNRS UMR5286, Claude Bernard Lyon 1 University, Cancer Research Center of Lyon, Lyon, France
Pathology Department, Reference Center for Rare Pituitary Diseases HYPO, ‘Groupement Hospitalier Est’ Hospices Civils de Lyon, Bron, France

Search for other papers by Alexandre Vasiljevic in
Google Scholar
PubMed Close
,
Emmanuel Jouanneau Inserm U1052, CNRS UMR5286, Claude Bernard Lyon 1 University, Cancer Research Center of Lyon, Lyon, France
Neurosurgery Department, Reference Center for Rare Pituitary Diseases HYPO, ‘Groupement Hospitalier Est’ Hospices Civils de Lyon, Bron, France

Search for other papers by Emmanuel Jouanneau in
Google Scholar
PubMed Close
, and
Gérald Raverot Inserm U1052, CNRS UMR5286, Claude Bernard Lyon 1 University, Cancer Research Center of Lyon, Lyon, France
Endocrinology Department, Reference Center for Rare Pituitary Diseases HYPO, ‘Groupement Hospitalier Est’ Hospices Civils de Lyon, Bron, France

Search for other papers by Gérald Raverot in
Google Scholar
PubMed Close

tumors, followed by a systematic review of all published cases, analyzing both treatment response and potential predictors of response and finishing with research and clinical perspectives. The aim is to highlight key clinical aspects that can already be

Article Type:
Research Article
DOI:
https://doi.org/10.1530/ERC-22-0037
Volume/Issue:
Volume 29: Issue 7
Restricted access
Hong-Jun Song Department of Nuclear Medicine, Postgraduate Department, Shanghai Sixth People's Hospital, Shanghai Jiao Tong University, 600 Yishan Road, Shanghai 200233, China

Search for other papers by Hong-Jun Song in
Google Scholar
PubMed Close
,
Yan-Li Xue Department of Nuclear Medicine, Postgraduate Department, Shanghai Sixth People's Hospital, Shanghai Jiao Tong University, 600 Yishan Road, Shanghai 200233, China
Department of Nuclear Medicine, Postgraduate Department, Shanghai Sixth People's Hospital, Shanghai Jiao Tong University, 600 Yishan Road, Shanghai 200233, China

Search for other papers by Yan-Li Xue in
Google Scholar
PubMed Close
,
Yan-Hong Xu Department of Nuclear Medicine, Postgraduate Department, Shanghai Sixth People's Hospital, Shanghai Jiao Tong University, 600 Yishan Road, Shanghai 200233, China
Department of Nuclear Medicine, Postgraduate Department, Shanghai Sixth People's Hospital, Shanghai Jiao Tong University, 600 Yishan Road, Shanghai 200233, China

Search for other papers by Yan-Hong Xu in
Google Scholar
PubMed Close
,
Zhong-Ling Qiu Department of Nuclear Medicine, Postgraduate Department, Shanghai Sixth People's Hospital, Shanghai Jiao Tong University, 600 Yishan Road, Shanghai 200233, China

Search for other papers by Zhong-Ling Qiu in
Google Scholar
PubMed Close
, and
Quan-Yong Luo Department of Nuclear Medicine, Postgraduate Department, Shanghai Sixth People's Hospital, Shanghai Jiao Tong University, 600 Yishan Road, Shanghai 200233, China

Search for other papers by Quan-Yong Luo in
Google Scholar
PubMed Close

131 I-SPECT/CT imaging fusion techniques, rare metastasis in DTC is increasingly becoming an incidental finding ( Chen et al . 2008 , Qiu et al . 2011 ). This pictorial review highlights the diagnostic aspects of 131 I-SPECT/CT for the localization

Article Type:
Research Article
DOI:
https://doi.org/10.1530/ERC-11-0068
Volume/Issue:
Volume 18: Issue 5
Free access
Sergio Vargas-Salas Department of Surgical Oncology, Faculty of Medicine, Pontificia Universidad Católica de Chile , Santiago, Chile

Search for other papers by Sergio Vargas-Salas in
Google Scholar
PubMed Close
,
José R Martínez Department of Surgical Oncology, Faculty of Medicine, Pontificia Universidad Católica de Chile , Santiago, Chile

Search for other papers by José R Martínez in
Google Scholar
PubMed Close
,
Soledad Urra Department of Surgical Oncology, Faculty of Medicine, Pontificia Universidad Católica de Chile , Santiago, Chile

Search for other papers by Soledad Urra in
Google Scholar
PubMed Close
,
José Miguel Domínguez Department of Endocrinology, Faculty of Medicine, Pontificia Universidad Católica de Chile, Santiago, Chile

Search for other papers by José Miguel Domínguez in
Google Scholar
PubMed Close
,
Natalia Mena GeneproDX, Santiago, Chile

Search for other papers by Natalia Mena in
Google Scholar
PubMed Close
,
Thomas Uslar Department of Internal Medicine, Pontificia Universidad Católica de Chile, Santiago, Chile

Search for other papers by Thomas Uslar in
Google Scholar
PubMed Close
,
Marcela Lagos Department of Clinical Laboratories, Faculty of Medicine, Pontificia Universidad Católica de Chile, Santiago, Chile

Search for other papers by Marcela Lagos in
Google Scholar
PubMed Close
,
Marcela Henríquez Department of Clinical Laboratories, Faculty of Medicine, Pontificia Universidad Católica de Chile, Santiago, Chile

Search for other papers by Marcela Henríquez in
Google Scholar
PubMed Close
, and
Hernán E González Department of Surgical Oncology, Faculty of Medicine, Pontificia Universidad Católica de Chile , Santiago, Chile

Search for other papers by Hernán E González in
Google Scholar
PubMed Close

interpretation, while helping to appropriately select patients that will benefit from molecular testing. This review is aimed to contribute to a better knowledge of the available molecular tests, their technical characteristics and clinical performance, through a

Article Type:
Review Article
DOI:
https://doi.org/10.1530/ERC-17-0405
Volume/Issue:
Volume 25: Issue 3
Open access
Emanuel Christ Division of Endocrinology, Diabetology and Metabolism, University Hospital of Basel, University of Basel, Basel, Switzerland
Center for Neuroendocrine and Endocrine Tumors, University Hospital Basel, Basel Switzerland

Search for other papers by Emanuel Christ in
Google Scholar
PubMed Close
,
Kwadwo Antwi Clinic of Radiology and Nuclear Medicine, University Hospital, Basel, Switzerland

Search for other papers by Kwadwo Antwi in
Google Scholar
PubMed Close
,
Melpomeni Fani Clinic of Radiology and Nuclear Medicine, University Hospital, Basel, Switzerland

Search for other papers by Melpomeni Fani in
Google Scholar
PubMed Close
, and
Damian Wild Center for Neuroendocrine and Endocrine Tumors, University Hospital Basel, Basel Switzerland
Clinic of Radiology and Nuclear Medicine, University Hospital, Basel, Switzerland

Search for other papers by Damian Wild in
Google Scholar
PubMed Close

is not a suitable diagnostic tool. Declaration of interest The authors declare that there is no conflict of interest that could be perceived as prejudicing the impartiality of this review. Funding The study was supported by the Swiss

Article Type:
Review Article
DOI:
https://doi.org/10.1530/ERC-19-0476
Volume/Issue:
Volume 27: Issue 4
Open access
Kellie L Jones
Search for other papers by Kellie L Jones in
Google Scholar
PubMed Close
and
Aman U Buzdar
Search for other papers by Aman U Buzdar in
Google Scholar
PubMed Close

suppression with luteinizing hormone releasing factor (LHRH) agonists offer different mechanisms to suppress estrogen production and action and these agents have better safety profiles compared with tamoxifen. This article will review each of these hormonal

Article Type:
Review Article
DOI:
https://doi.org/10.1677/erc.1.00594
Volume/Issue:
Volume 11: Issue 3
Free access